Provided is a compound having an AMPA receptor function enhancing action, and useful as a prophylactic or therapeutic drug for depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like. A compound represented by the formula (I):
wherein each symbol is as defined in the present specification,
or a salt thereof.
[EN] SULFONAMIDE DERIVATIVE AND USE THEREOF<br/>[FR] DÉRIVÉ DE SULFONAMIDE ET SON UTILISATION
申请人:TAKEDA PHARMACEUTICAL
公开号:WO2012137982A9
公开(公告)日:2013-02-14
US9527807B2
申请人:——
公开号:US9527807B2
公开(公告)日:2016-12-27
Fluorine substituted methoxyphenylalkyl amides as potent melatonin receptor agonists
作者:Andrew Tsotinis、Rodanthi Kompogennitaki、Ioannis Papanastasiou、Peter J. Garratt、Alina Bocianowska、David Sugden
DOI:10.1039/c8md00604k
日期:——
A series of fluorine substituted methoxyphenylalkyl amides were prepared with different orientations of the fluorine and methoxy groups with respect to the alkylamide sidechain and with alkyl sides of differing lengths (n = 1–3). β-Dimethyl and α-methyl derivatives were also synthesised. The compounds were tested as melatonin agonists and antagonists using the pigment aggregation of Xenopus melanophores